Cancer remains a significant risk to human health. Nanomedicine is a new multidisciplinary
field that is garnering a lot of interest and investigation. Nanomedicine shows great potential …

The initiation and development of major inflammatory diseases, ie, cancer, vascular
inflammation, and some autoimmune diseases are closely linked to the immune system …

Immune-checkpoint blockers (ICBs) have revolutionized oncology and firmly established the
subfield of immuno-oncology. Despite this renaissance, a subset of cancer patients remain …

Prostate cancer (PCa) is one of the most commonly diagnosed malignancies and among the
leading causes of cancer-related death worldwide. It is a highly heterogeneous disease …

In the last decade, immunotherapy has revolutionized the treatment landscape of several
hematological and solid malignancies, reporting unprecedented response rates …

Immunotherapy remains to be an appealing treatment option for prostate cancer with some
documented promise. Prostate cancer is traditionally considered as an immunologically …

Prostate cancer is the most commonly diagnosed cancer and the second leading cause of
cancer-related death among men in western countries. Androgen deprivation therapy (ADT) …

Rheumatoid arthritis (RA) is the most common immune-mediated inflammatory disease
characterized by chronic synovitis that hardly resolves spontaneously. The current treatment …

Simple Summary The treatment landscape of advanced prostate cancer (PCa) is constantly
improving with the approval of many new therapeutic options. Immunotherapy in PCa has …

Although immuno-oncotherapy in clinic has gained great success, the immunosuppressive
tumor microenvironment (TME) existing in the “cold” tumor with insufficient and exhausted …